✦ LIBER ✦

A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer

✍ Scribed by M. Venturini; C. Bighin; F. Puglisi; N. Olmeo; E. Aitini; G. Colucci; O. Garrone; A. Paccagnella; G. Marini; L. Crinò; M. Mansutti; B. Baconnet; A. Barbato; L. Del Mastro

Book ID: 113507189
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 262 KB
Volume: 19
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2010.01.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First line therapy with paclitaxel (Taxo

First line therapy with paclitaxel (Taxol®) and pegylated liposomal doxorubicin (Caelyx®) in patients with metastatic breast cancer: a multicentre phase II study

✍ D.A Vorobiof; B.L Rapoport; M.R Chasen; C Slabber; G McMichael; R Eek; C Mohamme 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Phase I/II study of gemcitabine with peg

Phase I/II study of gemcitabine with pegylated liposomal doxorubicin as first-line therapy in Asian women with metastatic breast cancer

✍ Zee-Wan Wong; Peter Cher-Siang Ang; Balram Chowbay; Nan-Soon Wong; Hui-Ti See; K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 185 KB

A phase I/II trial of non-pegylated lipo

A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer

✍ D. Amadori; C. Milandri; G. Comella; S. Saracchini; S. Salvagni; C. Barone; R. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Myotax: A phase II trial of docetaxel pl

Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines

✍ E. Curtit; P. Nouyrigat; N. Dohollou; E. Levy; A. Lortholary; J. Gligorov; T. Fa 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 356 KB

Non-pegylated liposomal doxorubicin and

Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase

✍ Peter Schmid; J. Krocker; R. Kreienberg; P. Klare; K. Kittel; H. Sommer; G. Hein 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 246 KB

Phase II study of gefitinib in combinati

Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer

✍ Ciardiello, F; Troiani, T; Caputo, F; De Laurentiis, M; Tortora, G; Palmieri, G; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 106 KB